Withings is a Smartwatches & Fitness company founded in 2008 and based in Issy-les-Moulineaux, France. It has raised $93.8M in total funding, most recently a Grant in 2024.

Withings launches BodyFit, a mid-range body composition scale with six-zone segmental tracking, expanding UK/Europe availability.
ScanWatch is Withings' flagship hybrid smartwatch line, pairing a classic analog dial with discreet medical-grade sensing. It offers on-demand ECG to screen for atrial fibrillation, SpO2 blood-oxygen measurement, sleep-apnea detection, and heart-rate and activity tracking, all with multi-week battery life rather than the daily charging of full touchscreen smartwatches. ScanWatch was among the first hybrid smartwatches to obtain medical-device certification in Europe, and the ScanWatch 2 added new health-sensing and an updated operating system, positioning the family at the clinical end of consumer wearables.
BPM Core is Withings' connected home health device combining three functions in one cuff: a blood-pressure monitor, a single-lead ECG, and a digital stethoscope that listens for valvular heart sounds. Readings sync to the Withings Health Mate app so users and, with sharing, their clinicians can track cardiovascular trends over time. It exemplifies Withings' strategy of moving clinically meaningful measurements out of the doctor's office and into a consumer device, complementing the company's wearables with at-home cardiac screening.
22 patents on file, but none with both an extractable figure and an abstract on Google Patents yet.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗